Syngene International Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Virtually debt-free
- Near 52-week low — potential value zone (₹375)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
SYNGENE · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 54.79% | 54.79% | 54.72% | 54.72% | 52.74% | 52.74% |
| FII | 21.20% | 20.92% | 20.64% | 20.72% | 20.65% | 19.47% |
| DII | 14.63% | 15.80% | 16.78% | 17.49% | 19.52% | 21.50% |
| Public | 9.07% | 8.18% | 7.44% | 6.74% | 6.79% | 5.99% |
| Others | 0.32% | 0.31% | 0.43% | 0.34% | 0.29% | 0.29% |
Corporate Events
To consider and approve the financial results for the period ended Jun 30, 2026
Dividend - Rs 1.25 Per Share
Record: 25 Jun 2026
Dividend - Rs 1.25 Per Share
Dividend - Rs 1.25 Per Share
Dividend - Rs 0.50 Per Share/Special Dividend - Rs 0.75 Per Share
Latest News
All newsSyngene to host analyst and investor meet
*Syngene to host analyst and investor meet* to discuss business updates and strategy. The event is part of routine investor engagement. No financial announcements or major updates were disclosed. Schedule details are available in the NSE filing. 📊 *STOCKS:* $SYNGENE | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AnalystMeet
Synergy Green hosts analyst call; no major updates disclosed
*Synergy Green hosts analyst call; no major updates disclosed.* The company shared operational insights during its investor meet, with no significant financial or strategic announcements. Recording of the call is available online for interested stakeholders. **No material data on earnings, guidance, or capex was released.** 📊 *STOCKS:* $SYNGENE | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #ConferenceCall
Synergy Green Industries issues general updates
*Synergy Green Industries issues general updates.* The company filed routine corporate updates with the NSE. No specific financial or operational details were disclosed. Such filings typically involve administrative or procedural information. 📊 *STOCKS:* $SYNGENE | 🏢 *SECTOR:* Corporate | #LOWIMPACT #corporate
Syngene International holds AGM, submits voting results
*Syngene International holds AGM, submits voting results*. Syngene International Limited has filed the scrutinizer's report of its Annual General Meeting held on **July 29, 2026**, with the stock exchange. The company disclosed the voting outcomes from the meeting. This is a routine corporate disclosure with no immediate financial implications. 📊 *STOCKS:* $SYNGENE | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.0K Cr 13.0% | ₹917.1 Cr 0.7% | ₹910.6 Cr 4.1% | ₹874.5 Cr 14.1% | ₹1.0K Cr 7.9% | ₹943.7 Cr 5.9% | ₹891 Cr 12.8% | ₹790 Cr |
| Op. Profit | ₹303.4 Cr 45.0% | ₹209.2 Cr 4.9% | ₹199.5 Cr 3.3% | ₹206.4 Cr 39.9% | ₹343.6 Cr 21.2% | ₹283.6 Cr 15.8% | ₹244.8 Cr 44.0% | ₹170 Cr |
| OPM | 29.3% 28.3% | 22.8% 4.1% | 21.9% 7.2% | 23.6% 30.1% | 33.8% 12.3% | 30.1% 9.4% | 27.5% 24.9% | 22.0% |
| Net Profit | ₹147.9 Cr 886.0% | ₹15 Cr 77.6% | ₹67.1 Cr 22.6% | ₹86.7 Cr 52.7% | ₹183.3 Cr 39.8% | ₹131.1 Cr 23.6% | ₹106.1 Cr 39.6% | ₹76 Cr |
| EPS (₹) | 3.67 891.9% | 0.37 77.8% | 1.67 22.3% | 2.15 52.7% | 4.55 39.6% | 3.26 23.5% | 2.64 40.4% | 1.88 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹3.7K Cr 2.7% | ₹3.6K Cr 4.4% | ₹3.5K Cr 9.3% | ₹3.2K Cr 22.6% | ₹2.6K Cr 19.2% | ₹2.2K Cr 8.5% | ₹2.0K Cr 10.2% | ₹1.8K Cr 28.3% | ₹1.4K Cr |
| Expenses | ₹2.8K Cr 8.4% | ₹2.6K Cr 5.1% | ₹2.5K Cr 9.8% | ₹2.3K Cr 21.0% | ₹1.9K Cr 23.5% | ₹1.5K Cr 8.1% | ₹1.4K Cr 8.1% | ₹1.3K Cr 35.8% | ₹949 Cr |
| Op. Profit | ₹921 Cr 11.9% | ₹1.0K Cr 2.8% | ₹1.0K Cr 8.0% | ₹942 Cr 26.8% | ₹743 Cr 9.6% | ₹678 Cr 9.7% | ₹618 Cr 15.1% | ₹537 Cr 13.3% | ₹474 Cr |
| OPM | 25.0% 13.8% | 29.0% 0.0% | 29.0% 3.3% | 30.0% 3.4% | 29.0% 6.5% | 31.0% 0.0% | 31.0% 6.9% | 29.0% 12.1% | 33.0% |
| Other Income | ₹-9 Cr 108.9% | ₹101 Cr 31.2% | ₹77 Cr 22.2% | ₹63 Cr 16.0% | ₹75 Cr 20.2% | ₹94 Cr 38.6% | ₹153 Cr 104.0% | ₹75 Cr 41.5% | ₹53 Cr |
| Interest | ₹49 Cr 7.5% | ₹53 Cr 12.8% | ₹47 Cr 4.4% | ₹45 Cr 87.5% | ₹24 Cr 14.3% | ₹28 Cr 20.0% | ₹35 Cr 9.4% | ₹32 Cr 39.1% | ₹23 Cr |
| Depreciation | ₹453 Cr 4.6% | ₹433 Cr 1.6% | ₹426 Cr 16.4% | ₹366 Cr 18.1% | ₹310 Cr 13.1% | ₹274 Cr 25.1% | ₹219 Cr 33.5% | ₹164 Cr 25.2% | ₹131 Cr |
| PBT | ₹411 Cr 37.7% | ₹660 Cr 6.3% | ₹621 Cr 4.5% | ₹594 Cr 22.7% | ₹484 Cr 3.2% | ₹469 Cr 9.3% | ₹517 Cr 24.6% | ₹415 Cr 11.6% | ₹372 Cr |
| Tax % | 23.0% 8.0% | 25.0% 38.9% | 18.0% 18.2% | 22.0% 22.2% | 18.0% 28.6% | 14.0% 30.0% | 20.0% 0.0% | 20.0% 11.1% | 18.0% |
| Net Profit | ₹317 Cr 36.1% | ₹496 Cr 2.7% | ₹510 Cr 9.9% | ₹464 Cr 17.2% | ₹396 Cr 2.2% | ₹405 Cr 1.7% | ₹412 Cr 24.1% | ₹332 Cr 8.9% | ₹305 Cr |
| EPS (₹) | 7.86 36.3% | 12.33 2.8% | 12.69 9.7% | 11.57 17.1% | 9.88 2.4% | 10.12 1.7% | 10.3 24.2% | 8.29 8.5% | 7.64 |
| Div Payout | 16.0% 60.0% | 10.0% 0.0% | 10.0% 9.1% | 11.0% 10.0% | 10.0% | 0.0% | 0.0% 100.0% | 3.0% 57.1% | 7.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
Liabilities | |||||||||
| Equity Capital | ₹403 Cr 0.2% | ₹402 Cr 0.0% | ₹402 Cr 0.2% | ₹401 Cr 0.0% | ₹401 Cr 0.3% | ₹400 Cr 0.0% | ₹400 Cr 100.0% | ₹200 Cr 0.0% | ₹200 Cr |
| Reserves | ₹4.4K Cr 2.6% | ₹4.3K Cr 12.1% | ₹3.9K Cr 19.9% | ₹3.2K Cr 11.0% | ₹2.9K Cr 19.7% | ₹2.4K Cr 36.3% | ₹1.8K Cr 0.5% | ₹1.8K Cr 16.3% | ₹1.5K Cr |
| Borrowings | ₹458 Cr 20.8% | ₹578 Cr 4.1% | ₹555 Cr 31.9% | ₹815 Cr 20.3% | ₹1.0K Cr 14.4% | ₹893 Cr 15.5% | ₹773 Cr 4.9% | ₹813 Cr 3.3% | ₹787 Cr |
| Other Liabilities | ₹1.8K Cr 17.8% | ₹1.5K Cr 11.4% | ₹1.3K Cr 4.2% | ₹1.4K Cr 12.3% | ₹1.2K Cr 6.5% | ₹1.2K Cr 3.7% | ₹1.2K Cr 31.7% | ₹922 Cr 35.4% | ₹681 Cr |
| Total Liabilities | ₹7.1K Cr 3.8% | ₹6.8K Cr 10.5% | ₹6.2K Cr 5.5% | ₹5.8K Cr 4.8% | ₹5.6K Cr 13.9% | ₹4.9K Cr 17.3% | ₹4.2K Cr 12.4% | ₹3.7K Cr 16.1% | ₹3.2K Cr |
Assets | |||||||||
| Fixed Assets | ₹3.0K Cr 7.1% | ₹2.8K Cr 1.7% | ₹2.9K Cr 6.9% | ₹2.7K Cr 11.5% | ₹2.4K Cr 8.7% | ₹2.2K Cr 9.0% | ₹2.0K Cr 46.7% | ₹1.4K Cr 33.7% | ₹1.0K Cr |
| CWIP | ₹1.0K Cr 17.4% | ₹1.3K Cr 51.1% | ₹838 Cr 373.4% | ₹177 Cr 48.8% | ₹346 Cr 46.0% | ₹237 Cr 1.3% | ₹234 Cr 14.6% | ₹274 Cr 76.8% | ₹155 Cr |
| Investments | ₹741 Cr 14.5% | ₹647 Cr 18.1% | ₹548 Cr 40.3% | ₹918 Cr 11.2% | ₹1.0K Cr 47.3% | ₹702 Cr 9.5% | ₹776 Cr 8.4% | ₹716 Cr 353.2% | ₹158 Cr |
| Other Assets | ₹2.3K Cr 9.0% | ₹2.1K Cr 8.6% | ₹1.9K Cr 7.4% | ₹2.1K Cr 15.6% | ₹1.8K Cr 2.7% | ₹1.7K Cr 53.8% | ₹1.1K Cr 15.3% | ₹1.3K Cr 27.6% | ₹1.8K Cr |
| Total Assets | ₹7.1K Cr 3.8% | ₹6.8K Cr 10.5% | ₹6.2K Cr 5.5% | ₹5.8K Cr 4.8% | ₹5.6K Cr 13.9% | ₹4.9K Cr 17.3% | ₹4.2K Cr 12.4% | ₹3.7K Cr 16.1% | ₹3.2K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹915 Cr 21.7% | ₹1.2K Cr 12.1% | ₹1.0K Cr 26.5% | ₹824 Cr 41.8% | ₹581 Cr 17.1% | ₹701 Cr 3.5% | ₹677 Cr 7.5% | ₹630 Cr 41.3% | ₹446 Cr |
| Investing CF | ₹-839 Cr 12.8% | ₹-744 Cr 50.6% | ₹-494 Cr 24.3% | ₹-653 Cr 6.9% | ₹-611 Cr 2.9% | ₹-629 Cr 48.3% | ₹-424 Cr 34.4% | ₹-646 Cr 85.1% | ₹-349 Cr |
| Financing CF | ₹-215 Cr 51.4% | ₹-142 Cr 74.2% | ₹-551 Cr 61.1% | ₹-342 Cr 1003.2% | ₹-31 Cr 153.4% | ₹58 Cr 125.7% | ₹-226 Cr 213.9% | ₹-72 Cr 8.9% | ₹-79 Cr |
| Net Cash Flow | ₹-138 Cr 149.1% | ₹281 Cr 7125.0% | ₹-4 Cr 97.7% | ₹-172 Cr 177.4% | ₹-62 Cr 147.7% | ₹130 Cr 364.3% | ₹28 Cr 131.8% | ₹-88 Cr 588.9% | ₹18 Cr |
| Free Cash Flow | ₹547 Cr 37.4% | ₹398 Cr 28.0% | ₹553 Cr 81.3% | ₹305 Cr 190.5% | ₹105 Cr 58.8% | ₹255 Cr 650.0% | ₹34 Cr 27.7% | ₹47 Cr 42.7% | ₹82 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 50d 5.7% | 53d 15.2% | 46d 24.6% | 61d 14.1% | 71d 10.1% | 79d 9.7% | 72d 5.9% | 68d 0.0% | 68d |
| Inventory Days | 56d 6.7% | 60d 36.2% | 94d 33.3% | 141d 62.1% | 87d 112.2% | 41d 127.8% | 18d 40.0% | 30d 63.4% | 82d |
| Days Payable | 138d 1.5% | 136d 36.0% | 100d 8.3% | 109d 3.5% | 113d 32.3% | 167d 7.1% | 156d 1.3% | 154d 21.0% | 195d |
| Cash Conv. Cycle | -32d 39.1% | -23d 157.5% | 40d 56.5% | 92d 104.4% | 45d 195.7% | -47d 28.8% | -66d 17.9% | -56d 27.3% | -44d |
| Working Capital Days | -68d 33.3% | -51d 88.9% | -27d 92.9% | -14d 67.4% | -43d 34.8% | -66d 61.6% | -172d 67.0% | -103d 114.6% | -48d |
| ROCE | 10.0% 23.1% | 13.0% 13.3% | 15.0% 0.0% | 15.0% 15.4% | 13.0% 7.1% | 14.0% 17.6% | 17.0% 0.0% | 17.0% | — |
Source: Screener.in · Lower days = better efficiency